D. McDonald

Phase 1/2a, open‐label, multicenter study of <scp>RM</scp>‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

David M. Cognetti, Jennifer M. Johnson, Joseph Curry et al. · Head & Neck · 2021 · 171 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).

David M. Cognetti, Jennifer M. Johnson, Joseph Curry et al. · Journal of Clinical Oncology · 2019 · 29 citations

Medicine, Pharmacology, Immunotherapy +16

RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.

Ann M. Gillenwater, David M. Cognetti, Jennifer M. Johnson et al. · Journal of Clinical Oncology · 2018 · 27 citations

Medicine, Oncology, Pharmacology +17

High lactate dehydrogenase level is associated with an adverse outlook in autografting for Hodgkin's disease.

Matthew Lumley, D W Milligan, C. Knechtli et al. · PubMed · 1996 · 19 citations

Life Sciences, Hematology, Immunology +4

Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphoma

A. Tulpule, Mark U. Rarick, Jonathan E. Kolitz et al. · Annals of Oncology · 2001 · 19 citations

Medicine, Oncology, Pharmacology +12